MedTrace Logo

Screening for Cancers in the Oral CAvity

NCT01958762 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-02-08

No results posted yet for this study

Summary

In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media).

The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.

Conditions

  • Oral Cavity Cancer

Interventions

OTHER

Invitation for oral cavity cancer screening

Sponsors & Collaborators

  • Picardy - Regional health agency (ARS)

    collaborator UNKNOWN

  • Regional Council Picardie

    collaborator UNKNOWN

  • Regional Observatory of Health and Social Issues in Picardie (OR2S)

    collaborator UNKNOWN

  • Association for the screening of diseases in Somme (Adema 80)

    collaborator UNKNOWN

  • Somme Cancer Registry

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Bernard DEVAUCHELLE, MD, phD · Amiens University Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01958762 on ClinicalTrials.gov